CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

Home About CADTH What We Do Programs and Services CADTH Common Drug Review Reports Oxycodone / naloxone

Oxycodone / naloxone

Last Updated: November 30, 2010

Result type: Reports

Project Number: S0219

Product Line: Common Drug Review

Generic Name: Oxycodone / naloxone

Brand Name: Targin

Manufacturer: Purdue Pharma

Indications: Pain, Moderate to severe and relief of opioid-induced constipation

Submission Type: New

Project Status: Cancelled

Oxycodone / naloxone

Files